Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site
I'm PortAI, I can summarize articles.
Mabtech and Sai Life Sciences have announced a strategic collaboration to enhance immunology research using the EYRA platform at Sai's Boston site. This partnership will provide advanced immunology assay services, including multiplex cytokine workflows, to biopharma and biotech companies. The EYRA platform offers efficient immune profiling capabilities, integrating advanced technology into Sai's discovery operations. Key elements of the collaboration include joint service delivery, co-branded demonstrations, and shared thought leadership, aimed at accelerating the development of immunology and immuno-oncology programs.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments